Pursuant to advisory issued by the Securities and Exchange Board of India (SEBI) vide its circular SEBI/HO/CFD/CMDI/CIR/P/2020/84 dated May 20, 2020 and Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)Regulations, 2015, please find enclosed herewith disclosure on material impact of COVID-19 pandemic on the Company.

pdf

Lasa Supergenerics Ltd.

13 Jun 2020

Company Update

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Change in Corporate Office Address

BSE India

In Compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, This is to inform you that Corporate office of the company is Shifted to office no 705, Minera Estate, A wing , 02 Commercial Tower , Mulund (W), Mumbai- 400 080.

pdf

Lasa Supergenerics Ltd.

12 Jun 2020

Company Update

Lasa Supergenerics Ltd - 540702 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to SEBI Circular CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please find enclosed copy of the of Annual Secretarial Compliance Report dated June 04, 2020, issued by Shivam Sharma & Associates, Secretarial Auditors of the Company, for the financial year 2019- 2020

pdf

Lasa Supergenerics Ltd.

10 Jun 2020

Result

Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Meeting Updates

BSE India

Further to our outcome of Board Meeting held on June 05, 2020 we are enclosing signed Audited Financial Results for the Quarter and Year ended March 31, 2020 along with Statement of Assets and Liabilities, Cash Flow statement & Audit Report for the year ended March 31, 2020.

pdf

Lasa Supergenerics Ltd.

10 Jun 2020

Company Update

Lasa Supergenerics Ltd - 540702 - Clarification

BSE India

With reference to last announcement disseminated on exchange website w r t Intimation of Board Meeting of Amarnath Securities Ltd you are requested to ignore the same as it is uploaded inadvertently

pdf

Lasa Supergenerics Ltd.

10 Jun 2020

Company Update

Lasa Supergenerics Ltd - 540702 - Clarification

BSE India

With reference to last announcement disseminated on exchange website w r t Intimation of Board Meeting of Amarnath Securities Ltd you are requested to ignore the same as it is uploaded inadvertently

pdf

Is Lasa Supergenerics Ltd. worth buying?

52 Votes:

Buy 76.92%

Sell 17.31%

Hold 5.77%